Effect of atorvastatin on mean platelet volume in new patients with hypercholesterolemia

Effect of atorvastatin on mean platelet volume in new patients with hypercholesterolemia: a before-after clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201706089014N168

Enrollment

Registered

2017-07-05

Start date

2016-12-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia. Pure hypercholesterolaemia

Interventions

Intervention 1: Intervention group: Atorvastatin capsule 40 mg daily for 2 months. Intervention 2: Control group: In comparison with before intervention.

Treatment - Drugs

Intervention group: Atorvastatin capsule 40 mg daily for 2 months.

Control group: In comparison with before intervention.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 65 years; new patients with hypercholesterolemia without history of treatment. Exclusion criteria: Thyroid disorders; hematologic disorders; sepsis; preeclampsia; diabetes; cardiovascular diseases; a history of major surgery or trauma in the past 2 weeks.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing serum cholesterol. Timepoint: before intervention and 2 months later. Method of measurement: through laboratory test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoya Khazaie

Shahid Beheshti Hospital

roya.khazaie@yahoo.com+98 81 3838 0283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026